Xie Y - Search Results

1

Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8⁺ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice.

Chen Y, Xie Y, Chan T, Sami A, Ahmed S, Liu Q, Xiang J. Chen Y, et al. Among authors: xie y. Cancer Gene Ther. 2011 Jul;18(7):489-99. doi: 10.1038/cgt.2011.18. Epub 2011 May 13. Cancer Gene Ther. 2011. PMID: 21566669 Free PMC article.

2

Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping.

Zhang J, Yu L, Fu Q, Gao J, Xie Y, Chen J, Zhang P, Liu Q, Zhao S. Zhang J, et al. Among authors: xie y. Gene. 2001 Feb 21;264(2):273-9. doi: 10.1016/s0378-1119(00)00597-7. Gene. 2001. PMID: 11250083

3

The effect of calcium (II) on the binding of anticoagulation factor I with activated coagulation factor X.

Xu X, Liu Q, Xie Y. Xu X, et al. Among authors: xie y. J Protein Chem. 2001 Jan;20(1):33-7. doi: 10.1023/a:1011001003818. J Protein Chem. 2001. PMID: 11330346

4

Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition.

Li W, Xie Y, Sun RW, Liu Q, Young J, Yu WY, Che CM, Tam PK, Ren Y. Li W, et al. Among authors: xie y. Br J Cancer. 2009 Jul 21;101(2):342-9. doi: 10.1038/sj.bjc.6605147. Epub 2009 Jun 23. Br J Cancer. 2009. PMID: 19550420 Free PMC article.

5

Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells.

Xie Y, Sheng W, Miao J, Xiang J, Yang J. Xie Y, et al. Cancer Gene Ther. 2011 Mar;18(3):176-88. doi: 10.1038/cgt.2010.67. Epub 2010 Nov 5. Cancer Gene Ther. 2011. PMID: 21052098 Free PMC article.

6

Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.

Zhu Y, Lv H, Xie Y, Sheng W, Xiang J, Yang J. Zhu Y, et al. Among authors: xie y. Cancer Gene Ther. 2011 Sep;18(9):627-36. doi: 10.1038/cgt.2011.31. Epub 2011 Jun 10. Cancer Gene Ther. 2011. PMID: 21660060

7

Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.

Ling C, Xie Y, Zhao D, Zhu Y, Xiang J, Yang J. Ling C, et al. Among authors: xie y. Cancer Gene Ther. 2012 Oct;19(10):697-706. doi: 10.1038/cgt.2012.50. Epub 2012 Aug 3. Cancer Gene Ther. 2012. PMID: 22863759

8

Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy.

Xu Y, Diao L, Chen Y, Liu Y, Wang C, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Deng D, Narod SA, Xie Y. Xu Y, et al. Among authors: xie y. Ann Oncol. 2013 Jun;24(6):1498-505. doi: 10.1093/annonc/mdt011. Epub 2013 Feb 13. Ann Oncol. 2013. PMID: 23406733 Free article.

9

Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.

Li D, Zhang Y, Xie Y, Xiang J, Zhu Y, Yang J. Li D, et al. Among authors: xie y. Cancer Gene Ther. 2013 Apr;20(4):251-9. doi: 10.1038/cgt.2013.14. Epub 2013 Mar 8. Cancer Gene Ther. 2013. PMID: 23470565

10

Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.

Xie Y, Chen Y, Ahmed KA, Li W, Ahmed S, Sami A, Chibbar R, Tang X, Tao M, Xu J, Xiang J. Xie Y, et al. Cancer Gene Ther. 2013 Oct;20(10):590-8. doi: 10.1038/cgt.2013.60. Epub 2013 Sep 20. Cancer Gene Ther. 2013. PMID: 24052129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,069 results

Search Page

Filters